E. K. RYU

1.3k total citations
63 papers, 1.1k citations indexed

About

E. K. RYU is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, E. K. RYU has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 17 papers in Organic Chemistry and 10 papers in Oncology. Recurrent topics in E. K. RYU's work include Ubiquitin and proteasome pathways (9 papers), Microtubule and mitosis dynamics (8 papers) and Antimicrobial Peptides and Activities (7 papers). E. K. RYU is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Microtubule and mitosis dynamics (8 papers) and Antimicrobial Peptides and Activities (7 papers). E. K. RYU collaborates with scholars based in South Korea, United States and Japan. E. K. RYU's co-authors include Malcolm MacCoss, Yearn Seong Choe, Byung‐Tae Kim, Kyung-Han Lee, Yong Choi, Xiaohong Chen, Zibo Li, Zhanhong Wu, Kai Chen and Jeong Kyu Bang and has published in prestigious journals such as Angewandte Chemie International Edition, Biomaterials and Molecular and Cellular Biology.

In The Last Decade

E. K. RYU

61 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. K. RYU South Korea 17 538 203 200 128 123 63 1.1k
Oktay K. Gasymov United States 21 677 1.3× 156 0.8× 181 0.9× 64 0.5× 154 1.3× 57 1.4k
Raphael Nudelman Israel 13 601 1.1× 107 0.5× 60 0.3× 118 0.9× 143 1.2× 22 1.2k
Piliang Hao China 27 1.6k 3.0× 517 2.5× 207 1.0× 280 2.2× 77 0.6× 72 2.3k
Xicheng Sun United States 16 716 1.3× 383 1.9× 65 0.3× 76 0.6× 123 1.0× 30 1.0k
Sylvia Els‐Heindl Germany 17 720 1.3× 170 0.8× 256 1.3× 171 1.3× 61 0.5× 31 1.2k
Judd Berman United States 20 852 1.6× 246 1.2× 120 0.6× 353 2.8× 80 0.7× 43 1.5k
David Timms United Kingdom 14 924 1.7× 374 1.8× 79 0.4× 119 0.9× 117 1.0× 27 1.3k
Michael K. Dunn United States 6 1.2k 2.2× 265 1.3× 153 0.8× 157 1.2× 53 0.4× 6 1.6k
Brian R. Hearn United States 17 811 1.5× 216 1.1× 30 0.1× 109 0.9× 90 0.7× 30 1.4k
Jan Markussen Denmark 30 1.7k 3.1× 239 1.2× 206 1.0× 173 1.4× 206 1.7× 65 3.1k

Countries citing papers authored by E. K. RYU

Since Specialization
Citations

This map shows the geographic impact of E. K. RYU's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. K. RYU with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. K. RYU more than expected).

Fields of papers citing papers by E. K. RYU

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. K. RYU. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. K. RYU. The network helps show where E. K. RYU may publish in the future.

Co-authorship network of co-authors of E. K. RYU

This figure shows the co-authorship network connecting the top 25 collaborators of E. K. RYU. A scholar is included among the top collaborators of E. K. RYU based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. K. RYU. E. K. RYU is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gunasekaran, P., Jihyeon Lee, Tae Wan Kim, et al.. (2025). N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer. Pharmaceutics. 17(8). 1027–1027. 1 indexed citations
2.
RYU, E. K., et al.. (2024). Aptamer and N-Degron Ensemble (AptaGron) as a Target Protein Degradation Strategy. ACS Chemical Biology. 19(12). 2462–2468. 2 indexed citations
3.
Gunasekaran, P., Jung Hoon Choi, E. K. RYU, et al.. (2021). Amphipathic Small Molecule AZT Compound Displays Potent Inhibitory Effects in Cancer Cell Proliferation. Pharmaceutics. 13(12). 2071–2071. 4 indexed citations
4.
Park, Jung‐Eun, Lingjun Meng, E. K. RYU, et al.. (2020). Autophosphorylation-induced self-assembly and STIL-dependent reinforcement underlie Plk4’s ring-to-dot localization conversion around a human centriole. Cell Cycle. 19(24). 3419–3436. 5 indexed citations
5.
Gunasekaran, P., Meiqi Fan, Eun Young Kim, et al.. (2019). Amphiphilic Triazine Polymer Derivatives as Antibacterial And Anti-atopic Agents in Mice Model. Scientific Reports. 9(1). 15161–15161. 17 indexed citations
6.
Park, Chanmi, Hye-Min Kim, Dong Hyun Kim, et al.. (2016). Ginsenoside Re Inhibits Osteoclast Differentiation in Mouse Bone Marrow-Derived Macrophages and Zebrafish Scale Model. Molecules and Cells. 39(12). 855–861. 21 indexed citations
7.
Ahn, Mija, P. Gunasekaran, Ganesan Rajasekaran, et al.. (2016). Pyrazole derived ultra-short antimicrobial peptidomimetics with potent anti-biofilm activity. European Journal of Medicinal Chemistry. 125. 551–564. 62 indexed citations
8.
Ahn, Mija, Binu Jacob, P. Gunasekaran, et al.. (2014). Poly-lysine peptidomimetics having potent antimicrobial activity without hemolytic activity. Amino Acids. 46(9). 2259–2269. 18 indexed citations
9.
Kim, Sungmin, et al.. (2013). Hybrid PET/MR imaging of tumors using an oleanolic acid-conjugated nanoparticle. Biomaterials. 34(33). 8114–8121. 51 indexed citations
10.
Choe, Yearn Seong, E. K. RYU, Byoung Wook Choi, et al.. (2007). Synthesis and evaluation of radioiodine-labelled CP-118,954 for the in-vivo imaging of acetylcholinesterase. Nuclear Medicine Communications. 28(7). 561–566. 4 indexed citations
11.
RYU, E. K., Yearn Seong Choe, Dong Hyun Kim, et al.. (2006). In vitro metabolism studies of 18F-labeled 1-phenylpiperazine using mouse liver S9 fraction. Nuclear Medicine and Biology. 33(2). 165–172. 8 indexed citations
12.
RYU, E. K., Yearn Seong Choe, Kyung-Han Lee, et al.. (2004). Synthesis of radioiodine labeled dibenzyl disulfide for evaluation of tumor cell uptake. Bioorganic & Medicinal Chemistry. 12(5). 859–864. 17 indexed citations
13.
Sohn, Sea Hwan, et al.. (2000). A methodological study on chromosome preparation for chick embryo; induction of high-resolution chromosomes by using ethidium bromide.. 42(2). 157–164. 2 indexed citations
14.
Kim, Jae Nyoung, et al.. (1999). Unusual Behaviour of N-Tosyl Pipecolinic Acid in Friedel-Crafts Reaction Conditions. Bulletin of the Korean Chemical Society. 20(7). 841–842. 1 indexed citations
15.
Jeon, Dong Ju, et al.. (1999). Diastereoselective Reduction and Grignard Reaction of 3-Aryltetrahydropenta[d]isoxazol-4-ones. Bulletin of the Korean Chemical Society. 20(1). 122–124.
16.
Jeon, Dong Ju, et al.. (1998). Electrophilic Substitution Reaction and A Novel [1,3] Rearrangement of 4-Lithio-5-p-toluenesulfonyloxypyrazoles. Bulletin of the Korean Chemical Society. 19(11). 1153–1155. 1 indexed citations
17.
Kim, Jae Nyoung, et al.. (1998). Chloroformyloxylation of Cinnamic Acid and Cinnamonitrile Derivatives by Using the HCI-DMF/Potassium Peroxymonosulfate (Oxone) System. Bulletin of the Korean Chemical Society. 19(8). 812–813. 4 indexed citations
18.
Jeon, Dong Ju, et al.. (1998). THE SYNTHESIS OF A NEW PYRAZOLYLIMIDAZOLINONE VIA 1,3-DIPOLAR CYCLOADDITION REACTION OF N-METHYL SYDNONE WITH METHYL PROPIOLATE. Bulletin of the Korean Chemical Society. 19(7). 725–726. 2 indexed citations
19.
Kim, Jae Nyoung, et al.. (1997). A facile Chloroformyloxylation Reaction of Olefins by Using the N,N-Dimethylformamid/Hydrogen Chlorid/m-Chloroperbenzoic Acid System. Bulletin of the Korean Chemical Society. 18(1). 110–111. 3 indexed citations
20.
RYU, E. K., et al.. (1995). ChemInform Abstract: An Improved Procedure for the Preparation of Aromatic Heterocyclic N‐ Oxides.. ChemInform. 26(29). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026